Last news
State Grid Jiangsu Electric Power Reports 13.49 GW of Offshore Wind Capacity Connected

State Grid Jiangsu Electric Power Reports 13.49 GW of Offshore Wind Capacity Connected

Jiangsu records the highest level of grid-connected offshore wind capacity among China's provinces NANJING, China, Jan. 19, 2026 /PRNewswire/ -- State Grid Jiangsu Electric Power Co., Ltd. reported that as of the end of 2025, Jiangsu's offshore wind...

Jiangsu 500kV Grid Project Enters Service, Ensuring Full Winter Peak Demand Support

Jiangsu 500kV Grid Project Enters Service, Ensuring Full Winter Peak Demand Support

NANJING, China, Jan. 19, 2026 /PRNewswire/ -- A newly completed 500kV power transmission project supporting the SPIC Binhai 2×1000MW unit expansion was successfully placed into operation in Jiangsu Province on January 13. As the first major energy...

Agoda reveals: Sapa, Vietnam is Asia's top emerging destination

Agoda reveals: Sapa, Vietnam is Asia's top emerging destination

SINGAPORE, Jan. 19, 2026 /PRNewswire/ -- Sapa (Vietnam) has emerged as the fastest growing destination for attracting international travelers in Asia, according to digital travel platform Agoda's latest New Horizons ranking. Vietnam's scenic...

Hong Kong Banquet Market Shifts Toward Smaller-Scale Events, Runhotel.hk Data Shows

Hong Kong Banquet Market Shifts Toward Smaller-Scale Events, Runhotel.hk Data Shows

HONG KONG, Jan. 19, 2026 /PRNewswire/ -- According to banquet enquiry data from the past year collected by Runhotel.hk's "Venue Search" platform, Hong Kong's banquet market is undergoing a noticeable shift, driven primarily by changing wedding...

D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002

D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002

SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- D3 Bio, a global clinical‑stage biotechnology company focused on developing transformative oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has cleared two...

Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration

Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and...

CNP Global Reignites the K-Kids Red Ginseng Beverage Category in Vietnam

CNP Global Reignites the K-Kids Red Ginseng Beverage Category in Vietnam

SEOUL, South Korea, Jan. 19, 2026 /PRNewswire/ -- CNP Global Co., Ltd. is a specialized development and outsource manufacturing company that develops beverages for children for both domestic and international markets. Aligned with its corporate...

WuXi AppTec Receives Double "A" Rating from CDP for Climate Change and Water Security Leadership

WuXi AppTec Receives Double "A" Rating from CDP for Climate Change and Water Security Leadership

SHANGHAI, Jan. 19, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced that it has been recognized on the "A List" for leadership in corporate...

1 ... 279 280 281 282 283 284 285 286 287 ... 3828
menu
menu